The results showed significantly higher FTH levels on erastin-treated and IL-1β-treated macrophages from AOSD patients (mean fold, 1.54 and 1.13, respectively) compared with those from HC subjects (0.35 and 0.40 respectively, both p < 0.001, Figure 3C,D). This evidence concerns the gene IL1B and adult-onset Still disease.